North York, Canada

Mohamed F M Mitwally

This inventor holds 5 USPTO granted patents. Top assignees: Ares Trading S.a., Wayne State University. Active years: 2010-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohamed F M Mitwally. Retrieved from https://idiyas.com/inventor/mohamed-f-m-mitwally

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.3

ph-index = 1


Location History:

  • North York, CA (2010 - 2011)
  • Bloomfield Hills, MI (US) (2014)

Company Filing History:


Years Active: 2010-2014

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Inventor Mohamed F M Mitwally

Introduction

Mohamed F M Mitwally is a notable inventor based in North York, Canada. He has made significant contributions to the field of medicine, particularly in the use of aromatase inhibitors for various surgical procedures. With a total of five patents to his name, Mitwally's work has the potential to enhance treatment outcomes for patients undergoing specific medical interventions.

Latest Patents

One of Mitwally's latest patents focuses on the use of aromatase inhibitors for endometrial thinning in preparation for surgical procedures on the endometrial cavity and uterus. This innovative approach involves administering aromatase inhibitors to female patients prior to endometrial ablation or resection procedures. The goal is to reduce the endometrial thickness to less than 6 mm, and preferably less than 4 mm, thereby improving the treatment outcome. The patent highlights the use of commercially available aromatase inhibitors, such as anastrozole, letrozole, and exemestane, which are well-tolerated and effective in decreasing serum estrogen levels.

Another significant patent by Mitwally addresses the treatment of ectopic pregnancy. Following a diagnosis of ectopic pregnancy, at least one aromatase inhibitor is administered to the patient, either alone or in combination with other therapeutic agents. This method aims to prevent the establishment and continuation of the ectopic pregnancy, with preferred embodiments including the administration of the aromatase inhibitor in conjunction with methotrexate.

Career Highlights

Throughout his career, Mitwally has worked with various organizations, including Ares Trading S.a. and Wayne State University. His experience in these institutions has contributed to his expertise in the field of medical innovations.

Collaborations

Mitwally has collaborated with notable colleagues, including Robert Frederic Casper and Michael P Diamond. These partnerships have likely enriched his research and development efforts in the medical field.

Conclusion

Mohamed F M Mitwally's contributions to the field of medicine through his innovative patents demonstrate his commitment to improving patient care. His work with aromatase inhibitors showcases the potential for advancements in surgical procedures and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…